{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T21:01:58Z","timestamp":1789678918283,"version":"4.0.1"},"reference-count":205,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1038\/s41401-026-01832-7","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T01:04:42Z","timestamp":1781831082000},"page":"2695-2708","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fibroblast growth factors in ischemic stroke: Therapeutic potential and clinical challenges"],"prefix":"10.1038","volume":"47","author":[{"given":"Confidence","family":"Dordoe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-ming","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Canol","family":"Bwalya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-ting","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-hao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-kun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,19]]},"reference":[{"key":"1832_CR1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/ageing\/afn282","volume":"38","author":"A Di Carlo","year":"2009","unstructured":"Di Carlo A. Human and economic burden of stroke. Age Ageing. 2009;38:4\u20135.","journal-title":"Age Ageing"},{"key":"1832_CR2","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1007\/s11906-011-0195-x","volume":"13","author":"C Sierra","year":"2011","unstructured":"Sierra C, Coca A, Schiffrin EL. Vascular mechanisms in the pathogenesis of stroke. Curr Hypertens Rep. 2011;13:200\u20137.","journal-title":"Curr Hypertens Rep"},{"key":"1832_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-023-02907-6","volume":"20","author":"J Larochelle","year":"2023","unstructured":"Larochelle J, Tishko RJ, Yang C, Ge Y, Phan LT, Gunraj RE, et al. Receptor-interacting protein kinase 2 (RIPK2) profoundly contributes to post-stroke neuroinflammation and behavioral deficits with microglia as unique perpetrators. J Neuroinflammation. 2023;20:221.","journal-title":"J Neuroinflammation"},{"key":"1832_CR4","doi-asserted-by":"crossref","unstructured":"Salaudeen MA, Bello N, Danraka RN, Ammani ML. Understanding the pathophysiology of ischemic stroke: the basis of current therapies and opportunity for new ones. Biomolecules. 2024;14:305.","DOI":"10.3390\/biom14030305"},{"key":"1832_CR5","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0140-6736(13)61953-4","volume":"383","author":"VL Feigin","year":"2014","unstructured":"Feigin VL, Forouzanfar MH, Krishnamurthi R, Mensah GA, Connor M, Bennett DA, et al. Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet. 2014;383:245\u201354.","journal-title":"Lancet"},{"key":"1832_CR6","doi-asserted-by":"crossref","unstructured":"Kuriakose D, Xiao Z. Pathophysiology and treatment of stroke: present status and future perspectives. Int J Mol Sci. 2020;21:7609.","DOI":"10.3390\/ijms21207609"},{"key":"1832_CR7","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/s41392-022-01064-1","volume":"7","author":"C Qin","year":"2022","unstructured":"Qin C, Yang S, Chu YH, Zhang H, Pang XW, Chen L, et al. Signaling pathways involved in ischemic stroke: molecular mechanisms and therapeutic interventions. Signal Transduct Target Ther. 2022;7:215.","journal-title":"Signal Transduct Target Ther"},{"key":"1832_CR8","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1586\/14737175.7.7.783","volume":"7","author":"S Kulkens","year":"2007","unstructured":"Kulkens S, Hacke W. Thrombolysis with alteplase for acute ischemic stroke: review of SITS-MOST and other Phase IV studies. Expert Rev Neurother. 2007;7:783\u20138.","journal-title":"Expert Rev Neurother"},{"key":"1832_CR9","doi-asserted-by":"publisher","first-page":"e344","DOI":"10.1161\/STR.0000000000000211","volume":"50","author":"WJ Powers","year":"2019","unstructured":"Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association\/American Stroke Association. Stroke. 2019;50:e344\u2013e418.","journal-title":"Stroke"},{"key":"1832_CR10","doi-asserted-by":"publisher","first-page":"CXXII","DOI":"10.1177\/23969873211024143","volume":"6","author":"T Steiner","year":"2021","unstructured":"Steiner T, Dichgans M, Norrving B, Aamodt AH, Berge E, Christensen H, et al. European Stroke Organisation (ESO) standard operating procedure for the preparation and publishing of guidelines. Eur Stroke J. 2021;6:CXXII\u2013CXXXIV.","journal-title":"Eur Stroke J"},{"key":"1832_CR11","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/S0140-6736(16)30962-X","volume":"389","author":"GJ Hankey","year":"2017","unstructured":"Hankey GJ. Stroke. Lancet. 2017;389:641\u201354.","journal-title":"Lancet"},{"key":"1832_CR12","doi-asserted-by":"crossref","unstructured":"Ardizzone A, Scuderi SA, Giuffrida D, Colarossi C, Puglisi C, Campolo M, et al. Role of fibroblast growth factors receptors (FGFRs) in brain tumors, focus on astrocytoma and glioblastoma. Cancers (Basel). 2020;12:3825.","DOI":"10.3390\/cancers12123825"},{"key":"1832_CR13","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nrd2792","volume":"8","author":"A Beenken","year":"2009","unstructured":"Beenken A, Mohammadi M. The FGF family: biology, pathophysiology and therapy. Nat Rev Drug Discov. 2009;8:235\u201353.","journal-title":"Nat Rev Drug Discov"},{"key":"1832_CR14","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/s42255-019-0074-3","volume":"1","author":"RM Gadaleta","year":"2019","unstructured":"Gadaleta RM, Moschetta A. Metabolic Messengers: fibroblast growth factor 15\/19. Nat Metab. 2019;1:588\u201394.","journal-title":"Nat Metab"},{"key":"1832_CR15","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.cytogfr.2005.03.002","volume":"16","author":"P Huang","year":"2005","unstructured":"Huang P, Stern MJ. FGF signaling in flies and worms: more and more relevant to vertebrate biology. Cytokine Growth Factor Rev. 2005;16:151\u20138.","journal-title":"Cytokine Growth Factor Rev"},{"key":"1832_CR16","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.cytogfr.2021.09.002","volume":"62","author":"L Yang","year":"2021","unstructured":"Yang L, Zhou F, Zheng D, Wang D, Li X, Zhao C, et al. FGF\/FGFR signaling: From lung development to respiratory diseases. Cytokine Growth Factor Rev. 2021;62:94\u2013104.","journal-title":"Cytokine Growth Factor Rev"},{"key":"1832_CR17","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/s41571-018-0115-y","volume":"16","author":"M Katoh","year":"2019","unstructured":"Katoh M. Fibroblast growth factor receptors as treatment targets in clinical oncology. Nat Rev Clin Oncol. 2019;16:105\u201322.","journal-title":"Nat Rev Clin Oncol"},{"key":"1832_CR18","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1111\/cns.14176","volume":"29","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Chen Z, Zhang K, Zhu J, Jin T. FGF\/FGFR system in the central nervous system demyelinating disease: recent progress and implications for multiple sclerosis. CNS Neurosci Ther. 2023;29:1497\u2013511.","journal-title":"CNS Neurosci Ther"},{"key":"1832_CR19","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.cytogfr.2023.07.005","volume":"74","author":"C Dordoe","year":"2023","unstructured":"Dordoe C, Huang W, Bwalya C, Wang X, Shen B, Wang H, et al. The role of microglial activation on ischemic stroke: modulation by fibroblast growth factors. Cytokine Growth Factor Rev. 2023;74:122\u201333.","journal-title":"Cytokine Growth Factor Rev"},{"key":"1832_CR20","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S0302-2838(03)00005-8","volume":"43","author":"MV Cronauer","year":"2003","unstructured":"Cronauer MV, Schulz WA, Seifert HH, Ackermann R, Burchardt M. Fibroblast growth factors and their receptors in urological cancers: basic research and clinical implications. Eur Urol. 2003;43:309\u201319.","journal-title":"Eur Urol"},{"key":"1832_CR21","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1002\/jcp.1041280317","volume":"128","author":"D Gospodarowicz","year":"1986","unstructured":"Gospodarowicz D, Cheng J. Heparin protects basic and acidic FGF from inactivation. J Cell Physiol. 1986;128:475\u201384.","journal-title":"J Cell Physiol"},{"key":"1832_CR22","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1093\/jb\/mvq121","volume":"149","author":"N Itoh","year":"2011","unstructured":"Itoh N, Ornitz DM. Fibroblast growth factors: from molecular evolution to roles in development, metabolism and disease. J Biochem. 2011;149:121\u201330.","journal-title":"J Biochem"},{"key":"1832_CR23","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/wdev.176","volume":"4","author":"DM Ornitz","year":"2015","unstructured":"Ornitz DM, Itoh N. The Fibroblast Growth Factor signaling pathway. Wiley Interdiscip Rev Dev Biol. 2015;4:215\u201366.","journal-title":"Wiley Interdiscip Rev Dev Biol"},{"key":"1832_CR24","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41392-020-00222-7","volume":"5","author":"Y Xie","year":"2020","unstructured":"Xie Y, Su N, Yang J, Tan Q, Huang S, Jin M, et al. FGF\/FGFR signaling in health and disease. Signal Transduct Target Ther. 2020;5:181.","journal-title":"Signal Transduct Target Ther"},{"key":"1832_CR25","doi-asserted-by":"publisher","first-page":"11405","DOI":"10.1074\/jbc.M600477200","volume":"281","author":"J Wesche","year":"2006","unstructured":"Wesche J, Malecki J, Wiedlocha A, Skjerpen CS, Claus P, Olsnes S. FGF-1 and FGF-2 require the cytosolic chaperone Hsp90 for translocation into the cytosol and the cell nucleus. J Biol Chem. 2006;281:11405\u201312.","journal-title":"J Biol Chem"},{"key":"1832_CR26","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.tig.2004.08.007","volume":"20","author":"N Itoh","year":"2004","unstructured":"Itoh N, Ornitz DM. Evolution of the FGF and FGFR gene families. Trends Genet. 2004;20:563\u20139.","journal-title":"Trends Genet"},{"key":"1832_CR27","volume":"2012","author":"S Oulion","year":"2012","unstructured":"Oulion S, Bertrand S, Escriva H. Evolution of the FGF gene family. Int J Evol Biol. 2012;2012:298147.","journal-title":"Int J Evol Biol"},{"key":"1832_CR28","doi-asserted-by":"publisher","first-page":"8083","DOI":"10.1074\/jbc.275.11.8083","volume":"275","author":"JM Revest","year":"2000","unstructured":"Revest JM, DeMoerlooze L, Dickson C. Fibroblast growth factor 9 secretion is mediated by a non-cleaved amino-terminal signal sequence. J Biol Chem. 2000;275:8083\u201390.","journal-title":"J Biol Chem"},{"key":"1832_CR29","doi-asserted-by":"publisher","first-page":"3417","DOI":"10.1128\/MCB.02249-06","volume":"27","author":"R Goetz","year":"2007","unstructured":"Goetz R, Beenken A, Ibrahimi OA, Kalinina J, Olsen SK, Eliseenkova AV, et al. Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members. Mol Cell Biol. 2007;27:3417\u201328.","journal-title":"Mol Cell Biol"},{"key":"1832_CR30","first-page":"15694","volume":"281","author":"X Zhang","year":"2006","unstructured":"Zhang X, Ibrahimi OA, Olsen SK, Umemori H, Mohammadi M, Ornitz DM. Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family. J Biol Chem. 2006;281:15694\u2013700.","journal-title":"The complete mammalian FGF family. J Biol Chem"},{"key":"1832_CR31","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1002\/humu.21067","volume":"30","author":"P Krejci","year":"2009","unstructured":"Krejci P, Prochazkova J, Bryja V, Kozubik A, Wilcox WR. Molecular pathology of the fibroblast growth factor family. Hum Mutat. 2009;30:1245\u201355.","journal-title":"Hum Mutat"},{"key":"1832_CR32","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.neuron.2007.07.006","volume":"55","author":"M Goldfarb","year":"2007","unstructured":"Goldfarb M, Schoorlemmer J, Williams A, Diwakar S, Wang Q, Huang X, et al. Fibroblast growth factor homologous factors control neuronal excitability through modulation of voltage-gated sodium channels. Neuron. 2007;55:449\u201363.","journal-title":"Neuron"},{"key":"1832_CR33","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1006\/geno.2000.6332","volume":"69","author":"M Wiedemann","year":"2000","unstructured":"Wiedemann M, Trueb B. Characterization of a novel protein (FGFRL1) from human cartilage related to FGF receptors. Genomics. 2000;69:275\u20139.","journal-title":"Genomics"},{"key":"1832_CR34","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/nrm3528","volume":"14","author":"R Goetz","year":"2013","unstructured":"Goetz R, Mohammadi M. Exploring mechanisms of FGF signalling through the lens of structural biology. Nat Rev Mol Cell Biol. 2013;14:166\u201380.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1832_CR35","doi-asserted-by":"crossref","unstructured":"Rehman S, Nadeem A, Akram U, Sarwar A, Quraishi A, Siddiqui H, et al. Molecular mechanisms of ischemic stroke: a review integrating clinical imaging and therapeutic perspectives. Biomedicines. 2024;12:812.","DOI":"10.3390\/biomedicines12040812"},{"key":"1832_CR36","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.neuron.2010.07.002","volume":"67","author":"MA Moskowitz","year":"2010","unstructured":"Moskowitz MA, Lo EH, Iadecola C. The science of stroke: mechanisms in search of treatments. Neuron. 2010;67:181\u201398.","journal-title":"Neuron"},{"key":"1832_CR37","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s40478-016-0371-y","volume":"4","author":"TV Nguyen","year":"2016","unstructured":"Nguyen TV, Frye JB, Zbesko JC, Stepanovic K, Hayes M, Urzua A, et al. Multiplex immunoassay characterization and species comparison of inflammation in acute and non-acute ischemic infarcts in human and mouse brain tissue. Acta Neuropathol Commun. 2016;4:100.","journal-title":"Acta Neuropathol Commun"},{"key":"1832_CR38","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.braindev.2012.01.009","volume":"35","author":"JY Park","year":"2013","unstructured":"Park JY, Byeon JH, Park SW, Eun SH, Chae KY, Eun BL. Neuroprotective effect of human placental extract on hypoxic-ischemic brain injury in neonatal rats. Brain Dev. 2013;35:68\u201374.","journal-title":"Brain Dev"},{"key":"1832_CR39","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/S1474-4422(11)70066-7","volume":"10","author":"R Macrez","year":"2011","unstructured":"Macrez R, Ali C, Toutirais O, Le Mauff B, Defer G, Dirnagl U, et al. Stroke and the immune system: from pathophysiology to new therapeutic strategies. Lancet Neurol. 2011;10:471\u201380.","journal-title":"Lancet Neurol"},{"key":"1832_CR40","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s12975-019-00744-5","volume":"11","author":"A Steliga","year":"2020","unstructured":"Steliga A, Kowianski P, Czuba E, Waskow M, Morys J, Lietzau G. Neurovascular unit as a source of ischemic stroke biomarkers-limitations of experimental studies and perspectives for clinical application. Transl Stroke Res. 2020;11:553\u201379.","journal-title":"Transl Stroke Res"},{"key":"1832_CR41","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1007\/s12975-020-00806-z","volume":"11","author":"A Datta","year":"2020","unstructured":"Datta A, Sarmah D, Mounica L, Kaur H, Kesharwani R, Verma G, et al. Cell death pathways in ischemic stroke and targeted pharmacotherapy. Transl Stroke Res. 2020;11:1185\u2013202.","journal-title":"Transl Stroke Res"},{"key":"1832_CR42","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.nurt.2010.07.005","volume":"7","author":"MA Yenari","year":"2010","unstructured":"Yenari MA, Kauppinen TM, Swanson RA. Microglial activation in stroke: therapeutic targets. Neurotherapeutics. 2010;7:378\u201391.","journal-title":"Neurotherapeutics"},{"key":"1832_CR43","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.neuint.2014.08.005","volume":"78","author":"Y Koyama","year":"2014","unstructured":"Koyama Y. Signaling molecules regulating phenotypic conversions of astrocytes and glial scar formation in damaged nerve tissues. Neurochem Int. 2014;78:35\u201342.","journal-title":"Neurochem Int"},{"key":"1832_CR44","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.neuint.2016.12.016","volume":"107","author":"NR Sims","year":"2017","unstructured":"Sims NR, Yew WP. Reactive astrogliosis in stroke: Contributions of astrocytes to recovery of neurological function. Neurochem Int. 2017;107:88\u2013103.","journal-title":"Neurochem Int"},{"key":"1832_CR45","doi-asserted-by":"publisher","first-page":"3388","DOI":"10.1096\/fj.201600495R","volume":"30","author":"D Li","year":"2016","unstructured":"Li D, Wang C, Yao Y, Chen L, Liu G, Zhang R, et al. mTORC1 pathway disruption ameliorates brain inflammation following stroke via a shift in microglia phenotype from M1 type to M2 type. FASEB J. 2016;30:3388\u201399.","journal-title":"FASEB J"},{"key":"1832_CR46","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1093\/infdis\/jiv499","volume":"213","author":"K Li","year":"2016","unstructured":"Li K, Wohlford-Lenane C, Perlman S, Zhao J, Jewell AK, Reznikov LR, et al. Middle east respiratory syndrome coronavirus causes multiple organ damage and lethal disease in mice transgenic for human dipeptidyl peptidase 4. J Infect Dis. 2016;213:712\u201322.","journal-title":"J Infect Dis"},{"key":"1832_CR47","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3389\/fneur.2018.00249","volume":"9","author":"XY Xiong","year":"2018","unstructured":"Xiong XY, Liu L, Yang QW. Refocusing neuroprotection in cerebral reperfusion era: new challenges and strategies. Front Neurol. 2018;9:249.","journal-title":"Front Neurol"},{"key":"1832_CR48","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s00401-017-1667-0","volume":"133","author":"CJ Sommer","year":"2017","unstructured":"Sommer CJ. Ischemic stroke: experimental models and reality. Acta Neuropathol. 2017;133:245\u201361.","journal-title":"Acta Neuropathol"},{"key":"1832_CR49","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jneumeth.2015.04.008","volume":"249","author":"HK Smith","year":"2015","unstructured":"Smith HK, Russell JM, Granger DN, Gavins FN. Critical differences between two classical surgical approaches for middle cerebral artery occlusion-induced stroke in mice. J Neurosci Methods. 2015;249:99\u2013105.","journal-title":"J Neurosci Methods"},{"key":"1832_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2022.109064","volume":"212","author":"C Dordoe","year":"2022","unstructured":"Dordoe C, Wang X, Lin P, Wang Z, Hu J, Wang D, et al. Non-mitogenic fibroblast growth factor 1 protects against ischemic stroke by regulating microglia\/macrophage polarization through Nrf2 and NF-kappaB pathways. Neuropharmacology. 2022;212:109064.","journal-title":"Neuropharmacology"},{"key":"1832_CR51","doi-asserted-by":"publisher","first-page":"e0153756","DOI":"10.1371\/journal.pone.0153756","volume":"11","author":"C Qian","year":"2016","unstructured":"Qian C, Li PC, Jiao Y, Yao HH, Chen YC, Yang J, et al. Precise characterization of the penumbra revealed by MRI: a modified photothrombotic stroke model study. PLoS One. 2016;11:e0153756.","journal-title":"PLoS One"},{"key":"1832_CR52","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/scrt519","volume":"5","author":"L Huang","year":"2014","unstructured":"Huang L, Wong S, Snyder EY, Hamblin MH, Lee JP. Human neural stem cells rapidly ameliorate symptomatic inflammation in early-stage ischemic-reperfusion cerebral injury. Stem Cell Res Ther. 2014;5:129.","journal-title":"Stem Cell Res Ther"},{"key":"1832_CR53","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.neuron.2014.03.003","volume":"82","author":"D Knowland","year":"2014","unstructured":"Knowland D, Arac A, Sekiguchi KJ, Hsu M, Lutz SE, Perrino J, et al. Stepwise recruitment of transcellular and paracellular pathways underlies blood-brain barrier breakdown in stroke. Neuron. 2014;82:603\u201317.","journal-title":"Neuron"},{"key":"1832_CR54","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1179\/1743132810Y.0000000004","volume":"33","author":"X Cheng","year":"2011","unstructured":"Cheng X, Wang Z, Yang J, Ma M, Lu T, Xu G, et al. Acidic fibroblast growth factor delivered intranasally induces neurogenesis and angiogenesis in rats after ischemic stroke. Neurol Res. 2011;33:675\u201380.","journal-title":"Neurol Res"},{"key":"1832_CR55","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.neuroscience.2015.07.074","volume":"305","author":"MJ Tsai","year":"2015","unstructured":"Tsai MJ, Tsai SK, Huang MC, Liou DY, Huang SL, Hsieh WH, et al. Acidic FGF promotes neurite outgrowth of cortical neurons and improves neuroprotective effect in a cerebral ischemic rat model. Neuroscience. 2015;305:238\u201347.","journal-title":"Neuroscience"},{"key":"1832_CR56","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1080\/01616412.1995.11740350","volume":"17","author":"P Cuevas","year":"1995","unstructured":"Cuevas P, Carceller F, Gimenez-Gallego G. Acidic fibroblast growth factor prevents death of spinal cord motoneurons in newborn rats after nerve section. Neurol Res. 1995;17:396\u20139.","journal-title":"Neurol Res"},{"key":"1832_CR57","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/jgm.1568","volume":"13","author":"WC Huang","year":"2011","unstructured":"Huang WC, Kuo HS, Tsai MJ, Ma H, Chiu CW, Huang MC, et al. Adeno-associated virus-mediated human acidic fibroblast growth factor expression promotes functional recovery of spinal cord-contused rats. J Gene Med. 2011;13:283\u20139.","journal-title":"J Gene Med"},{"key":"1832_CR58","doi-asserted-by":"publisher","first-page":"3884","DOI":"10.1007\/s12035-021-02367-0","volume":"58","author":"L Klimaschewski","year":"2021","unstructured":"Klimaschewski L, Claus P. Fibroblast growth factor signalling in the diseased nervous system. Mol Neurobiol. 2021;58:3884\u2013902.","journal-title":"Mol Neurobiol"},{"key":"1832_CR59","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/0197-0186(92)90184-S","volume":"21","author":"A Mitani","year":"1992","unstructured":"Mitani A, Oomura Y, Yanase H, Kataoka K. Acidic fibroblast growth factor delays in vitro ischemia-induced intracellular calcium elevation in gerbil hippocampal slices: a sign of neuroprotection. Neurochem Int. 1992;21:337\u201341.","journal-title":"Neurochem Int"},{"key":"1832_CR60","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/0197-0186(92)90190-3","volume":"21","author":"K Sasaki","year":"1992","unstructured":"Sasaki K, Oomura Y, Suzuki K, Hanai K, Yagi H. Acidic fibroblast growth factor prevents death of hippocampal CA1 pyramidal cells following ischemia. Neurochem Int. 1992;21:397\u2013402.","journal-title":"Neurochem Int"},{"key":"1832_CR61","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0090-3019(97)00193-6","volume":"49","author":"P Cuevas","year":"1998","unstructured":"Cuevas P, Carceller F, Munoz-Willery I, Gimenez-Gallego G. Intravenous fibroblast growth factor penetrates the blood-brain barrier and protects hippocampal neurons against ischemia-reperfusion injury. Surg Neurol. 1998;49:77\u201383.","journal-title":"Surg Neurol"},{"key":"1832_CR62","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s11481-013-9501-5","volume":"9","author":"ME Woodbury","year":"2014","unstructured":"Woodbury ME, Ikezu T. Fibroblast growth factor-2 signaling in neurogenesis and neurodegeneration. J Neuroimmune Pharmacol. 2014;9:92\u2013101.","journal-title":"J Neuroimmune Pharmacol"},{"key":"1832_CR63","doi-asserted-by":"publisher","first-page":"44735","DOI":"10.18632\/oncotarget.8203","volume":"7","author":"MR Akl","year":"2016","unstructured":"Akl MR, Nagpal P, Ayoub NM, Tai B, Prabhu SA, Capac CM, et al. Molecular and clinical significance of fibroblast growth factor 2 (FGF2\/bFGF) in malignancies of solid and hematological cancers for personalized therapies. Oncotarget. 2016;7:44735\u201362.","journal-title":"Oncotarget"},{"key":"1832_CR64","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.brainres.2010.10.063","volume":"1367","author":"X Bao","year":"2011","unstructured":"Bao X, Wei J, Feng M, Lu S, Li G, Dou W, et al. Transplantation of human bone marrow-derived mesenchymal stem cells promotes behavioral recovery and endogenous neurogenesis after cerebral ischemia in rats. Brain Res. 2011;1367:103\u201313.","journal-title":"Brain Res"},{"key":"1832_CR65","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1161\/01.STR.0000094421.61917.71","volume":"34","author":"K Wada","year":"2003","unstructured":"Wada K, Sugimori H, Bhide PG, Moskowitz MA, Finklestein SP. Effect of basic fibroblast growth factor treatment on brain progenitor cells after permanent focal ischemia in rats. Stroke. 2003;34:2722\u20138.","journal-title":"Stroke"},{"key":"1832_CR66","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.671131","volume":"12","author":"C Dordoe","year":"2021","unstructured":"Dordoe C, Chen K, Huang W, Chen J, Hu J, Wang X, et al. Roles of fibroblast growth factors and their therapeutic potential in treatment of ischemic stroke. Front Pharmacol. 2021;12:671131.","journal-title":"Front Pharmacol"},{"key":"1832_CR67","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1161\/01.STR.0000190006.88896.d3","volume":"36","author":"N Ikeda","year":"2005","unstructured":"Ikeda N, Nonoguchi N, Zhao MZ, Watanabe T, Kajimoto Y, Furutama D, et al. Bone marrow stromal cells that enhanced fibroblast growth factor-2 secretion by herpes simplex virus vector improve neurological outcome after transient focal cerebral ischemia in rats. Stroke. 2005;36:2725\u201330.","journal-title":"Stroke"},{"key":"1832_CR68","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.expneurol.2008.11.011","volume":"216","author":"D Sun","year":"2009","unstructured":"Sun D, Bullock MR, McGinn MJ, Zhou Z, Altememi N, Hagood S, et al. Basic fibroblast growth factor-enhanced neurogenesis contributes to cognitive recovery in rats following traumatic brain injury. Exp Neurol. 2009;216:56\u201365.","journal-title":"Exp Neurol"},{"key":"1832_CR69","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1006\/exnr.2002.7994","volume":"177","author":"Q Li","year":"2002","unstructured":"Li Q, Stephenson D. Postischemic administration of basic fibroblast growth factor improves sensorimotor function and reduces infarct size following permanent focal cerebral ischemia in the rat. Exp Neurol. 2002;177:531\u20137.","journal-title":"Exp Neurol"},{"key":"1832_CR70","doi-asserted-by":"publisher","first-page":"331","DOI":"10.3389\/fcell.2019.00331","volume":"7","author":"Z Koledova","year":"2019","unstructured":"Koledova Z, Sumbal J, Rabata A, de La Bourdonnaye G, Chaloupkova R, Hrdlickova B, et al. Fibroblast growth factor 2 protein stability provides decreased dependence on heparin for induction of FGFR signaling and alters ERK signaling dynamics. Front Cell Dev Biol. 2019;7:331.","journal-title":"Front Cell Dev Biol"},{"key":"1832_CR71","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1159\/000015941","volume":"9","author":"H Ay","year":"1999","unstructured":"Ay H, Ay I, Koroshetz WJ, Finklestein SP. Potential usefulness of basic fibroblast growth factor as a treatment for stroke. Cerebrovasc Dis. 1999;9:131\u20135.","journal-title":"Cerebrovasc Dis"},{"key":"1832_CR72","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1161\/01.STR.24.11.1735","volume":"24","author":"V MacMillan","year":"1993","unstructured":"MacMillan V, Judge D, Wiseman A, Settles D, Swain J, Davis J. Mice expressing a bovine basic fibroblast growth factor transgene in the brain show increased resistance to hypoxemic-ischemic cerebral damage. Stroke. 1993;24:1735\u20139.","journal-title":"Stroke"},{"key":"1832_CR73","doi-asserted-by":"publisher","first-page":"6006","DOI":"10.1523\/JNEUROSCI.19-14-06006.1999","volume":"19","author":"JP Wagner","year":"1999","unstructured":"Wagner JP, Black IB, DiCicco-Bloom E. Stimulation of neonatal and adult brain neurogenesis by subcutaneous injection of basic fibroblast growth factor. J Neurosci. 1999;19:6006\u201316.","journal-title":"J Neurosci"},{"key":"1832_CR74","doi-asserted-by":"publisher","first-page":"3012","DOI":"10.1073\/pnas.83.9.3012","volume":"83","author":"P Walicke","year":"1986","unstructured":"Walicke P, Cowan WM, Ueno N, Baird A, Guillemin R. Fibroblast growth factor promotes survival of dissociated hippocampal neurons and enhances neurite extension. Proc Natl Acad Sci USA. 1986;83:3012\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1832_CR75","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0079-6123(08)60301-5","volume":"78","author":"PA Walicke","year":"1988","unstructured":"Walicke PA, Baird A. Trophic effects of fibroblast growth factor on neural tissue. Prog Brain Res. 1988;78:333\u20138.","journal-title":"Prog Brain Res"},{"key":"1832_CR76","doi-asserted-by":"publisher","DOI":"10.1038\/srep19869","volume":"6","author":"YH Li","year":"2016","unstructured":"Li YH, Fu HL, Tian ML, Wang YQ, Chen W, Cai LL, et al. Neuron-derived FGF10 ameliorates cerebral ischemia injury via inhibiting NF-kappaB-dependent neuroinflammation and activating PI3K\/Akt survival signaling pathway in mice. Sci Rep. 2016;6:19869.","journal-title":"Sci Rep"},{"key":"1832_CR77","doi-asserted-by":"publisher","first-page":"3156","DOI":"10.1101\/gad.12.20.3156","volume":"12","author":"H min","year":"1998","unstructured":"Min H, Danilenko DM, Scully SA, Bolon B, Ring BD, Tarpley JE, et al. FGF-10 is required for both limb and lung development and exhibits striking functional similarity to Drosophila branchless. Genes Dev. 1998;12:3156\u201361.","journal-title":"Genes Dev"},{"key":"1832_CR78","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1101\/gad.983202","volume":"16","author":"H Sakaue","year":"2002","unstructured":"Sakaue H, Konishi M, Ogawa W, Asaki T, Mori T, Yamasaki M, et al. Requirement of fibroblast growth factor 10 in development of white adipose tissue. Genes Dev. 2002;16:908\u201312.","journal-title":"Genes Dev"},{"key":"1832_CR79","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1006\/jsre.1998.5501","volume":"81","author":"PA Jimenez","year":"1999","unstructured":"Jimenez PA, Rampy MA. Keratinocyte growth factor-2 accelerates wound healing in incisional wounds. J Surg Res. 1999;81:238\u201342.","journal-title":"J Surg Res"},{"key":"1832_CR80","doi-asserted-by":"publisher","first-page":"3693","DOI":"10.1242\/dev.126.16.3693","volume":"126","author":"AA Thomson","year":"1999","unstructured":"Thomson AA, Cunha GR. Prostatic growth and development are regulated by FGF10. Development. 1999;126:3693\u2013701.","journal-title":"Development"},{"key":"1832_CR81","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.bbrc.2014.11.063","volume":"456","author":"YH Li","year":"2015","unstructured":"Li YH, Yang LY, Chen W, Li YK, Yuan HB. Fibroblast growth factor 10 protects neuron against oxygen-glucose deprivation injury through inducing heme oxygenase-1. Biochem Biophys Res Commun. 2015;456:225\u201331.","journal-title":"Biochem Biophys Res Commun"},{"key":"1832_CR82","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1242\/dev.127.3.483","volume":"127","author":"L Moerlooze","year":"2000","unstructured":"Moerlooze L, Spencer-Dene B, Revest JM, Hajihosseini M, Rosewell I, Dickson C. An important role for the IIIb isoform of fibroblast growth factor receptor 2 (FGFR2) in mesenchymal-epithelial signalling during mouse organogenesis. Development. 2000;127:483\u201392.","journal-title":"Development"},{"key":"1832_CR83","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1097\/01.WCB.0000100063.36077.CD","volume":"24","author":"JL Ellsworth","year":"2004","unstructured":"Ellsworth JL, Garcia R, Yu J, Kindy MS. Time window of fibroblast growth factor-18-mediated neuroprotection after occlusion of the middle cerebral artery in rats. J Cereb Blood Flow Metab. 2004;24:114\u201323.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1832_CR84","doi-asserted-by":"publisher","first-page":"18161","DOI":"10.1074\/jbc.273.29.18161","volume":"273","author":"N Ohbayashi","year":"1998","unstructured":"Ohbayashi N, Hoshikawa M, Kimura S, Yamasaki M, Fukui S, Itoh N. Structure and expression of the mRNA encoding a novel fibroblast growth factor, FGF-18. J Biol Chem. 1998;273:18161\u20134.","journal-title":"J Biol Chem"},{"key":"1832_CR85","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1159\/000056775","volume":"90","author":"TE Whitmore","year":"2000","unstructured":"Whitmore TE, Maurer MF, Sexson S, Raymond F, Conklin D, Deisher TA. Assignment of fibroblast growth factor 18 (FGF18) to human chromosome 5q34 by use of radiation hybrid mapping and fluorescence in situ hybridization. Cytogenet Cell Genet. 2000;90:231\u20133.","journal-title":"Cytogenet Cell Genet"},{"key":"1832_CR86","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1161\/01.STR.0000071760.66720.5F","volume":"34","author":"JL Ellsworth","year":"2003","unstructured":"Ellsworth JL, Garcia R, Yu J, Kindy MS. Fibroblast growth factor-18 reduced infarct volumes and behavioral deficits after transient occlusion of the middle cerebral artery in rats. Stroke. 2003;34:1507\u201312.","journal-title":"Stroke"},{"key":"1832_CR87","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/S0169-328X(02)00393-5","volume":"105","author":"M Hoshikawa","year":"2002","unstructured":"Hoshikawa M, Yonamine A, Konishi M, Itoh N. FGF-18 is a neuron-derived glial cell growth factor expressed in the rat brain during early postnatal development. Brain Res Mol Brain Res. 2002;105:60\u20136.","journal-title":"Brain Res Mol Brain Res"},{"key":"1832_CR88","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.590669","volume":"11","author":"J Chen","year":"2020","unstructured":"Chen J, Wang X, Hu J, Du J, Dordoe C, Zhou Q, et al. FGF20 protected against BBB disruption after traumatic brain injury by upregulating junction protein expression and inhibiting the inflammatory response. Front Pharmacol. 2020;11:590669.","journal-title":"Front Pharmacol"},{"key":"1832_CR89","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.124.036721","volume":"13","author":"K Chen","year":"2024","unstructured":"Chen K, Huang W, Hu B, Fu F, Cao Y, Xu H, et al. Mediation analysis of serum fibroblast growth factor 20 and poor prognosis after ischemic stroke. J Am Heart Assoc. 2024;13:e036721.","journal-title":"J Am Heart Assoc"},{"key":"1832_CR90","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1006\/bbrc.2000.3142","volume":"274","author":"H Kirikoshi","year":"2000","unstructured":"Kirikoshi H, Sagara N, Saitoh T, Tanaka K, Sekihara H, Shiokawa K, et al. Molecular cloning and characterization of human FGF-20 on chromosome 8p21.3-p22. Biochem Biophys Res Commun. 2000;274:337\u201343.","journal-title":"Biochem Biophys Res Commun"},{"key":"1832_CR91","doi-asserted-by":"publisher","DOI":"10.1016\/j.diff.2023.10.005","volume":"139","author":"JD Van Greenen","year":"2024","unstructured":"Van Greenen JD, Hockman D. Fgf20. Differentiation. 2024;139:100737.","journal-title":"Differentiation"},{"key":"1832_CR92","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1006\/bbrc.2000.3675","volume":"277","author":"S Ohmachi","year":"2000","unstructured":"Ohmachi S, Watanabe Y, Mikami T, Kusu N, Ibi T, Akaike A, et al. FGF-20, a novel neurotrophic factor, preferentially expressed in the substantia nigra pars compacta of rat brain. Biochem Biophys Res Commun. 2000;277:355\u201360.","journal-title":"Biochem Biophys Res Commun"},{"key":"1832_CR93","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/j.neuropharm.2012.07.029","volume":"63","author":"IJ Sleeman","year":"2012","unstructured":"Sleeman IJ, Boshoff EL, Duty S. Fibroblast growth factor-20 protects against dopamine neuron loss in vitro and provides functional protection in the 6-hydroxydopamine-lesioned rat model of Parkinson\u2019s disease. Neuropharmacology. 2012;63:1268\u201377.","journal-title":"Neuropharmacology"},{"key":"1832_CR94","doi-asserted-by":"publisher","first-page":"9750","DOI":"10.1523\/JNEUROSCI.2745-06.2006","volume":"26","author":"S Murase","year":"2006","unstructured":"Murase S, McKay RD. A specific survival response in dopamine neurons at most risk in Parkinson\u2019s disease. J Neurosci. 2006;26:9750\u201360.","journal-title":"J Neurosci"},{"key":"1832_CR95","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.1161\/STROKEAHA.125.050828","volume":"56","author":"S Ye","year":"2025","unstructured":"Ye S, Zhao Y, Xu Y, Liang F, Wu R, Zhang Y, et al. Intracerebral delivery of rhFGF20 via heparin-poloxamer hydrogel promotes neurological recovery in ischemic stroke. Stroke. 2025;56:2707\u201319.","journal-title":"Stroke"},{"key":"1832_CR96","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1016\/S0021-9258(19)41631-1","volume":"250","author":"D Gospodarowicz","year":"1975","unstructured":"Gospodarowicz D. Purification of a fibroblast growth factor from bovine pituitary. J Biol Chem. 1975;250:2515\u201320.","journal-title":"J Biol Chem"},{"key":"1832_CR97","doi-asserted-by":"publisher","first-page":"3590","DOI":"10.3748\/wjg.v10.i24.3590","volume":"10","author":"XB Fu","year":"2004","unstructured":"Fu XB, Li XK, Wang T, Cheng B, Sheng ZY. Enhanced anti-apoptosis and gut epithelium protection function of acidic fibroblast growth factor after cancelling of its mitogenic activity. World J Gastroenterol. 2004;10:3590\u20136.","journal-title":"World J Gastroenterol"},{"key":"1832_CR98","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.kint.2017.05.013","volume":"93","author":"G Liang","year":"2018","unstructured":"Liang G, Song L, Chen Z, Qian Y, Xie J, Zhao L, et al. Fibroblast growth factor 1 ameliorates diabetic nephropathy by an anti-inflammatory mechanism. Kidney Int. 2018;93:95\u2013109.","journal-title":"Kidney Int"},{"key":"1832_CR99","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.bbi.2019.10.015","volume":"83","author":"Y Li","year":"2020","unstructured":"Li Y, Chen N, Wu C, Lu Y, Gao G, Duan C, et al. Galectin-1 attenuates neurodegeneration in Parkinson\u2019s disease model by modulating microglial MAPK\/IkappaB\/NFkappaB axis through its carbohydrate-recognition domain. Brain Behav Immun. 2020;83:214\u201325.","journal-title":"Brain Behav Immun"},{"key":"1832_CR100","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-019-1538-9","volume":"16","author":"M Zusso","year":"2019","unstructured":"Zusso M, Lunardi V, Franceschini D, Pagetta A, Lo R, Stifani S, et al. Ciprofloxacin and levofloxacin attenuate microglia inflammatory response via TLR4\/NF-\u03baB pathway. J Neuroinflammation. 2019;16:148.","journal-title":"J Neuroinflammation"},{"key":"1832_CR101","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2019.108754","volume":"310","author":"H Li","year":"2019","unstructured":"Li H, Shi Y, Wang X, Li P, Zhang S, Wu T, et al. Piceatannol alleviates inflammation and oxidative stress via modulation of the Nrf2\/HO-1 and NF-kappaB pathways in diabetic cardiomyopathy. Chem Biol Interact. 2019;310:108754.","journal-title":"Chem Biol Interact"},{"key":"1832_CR102","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s00109-015-1338-3","volume":"94","author":"Y Wu","year":"2016","unstructured":"Wu Y, Chen X, Ge X, Xia H, Wang Y, Su S, et al. Isoliquiritigenin prevents the progression of psoriasis-like symptoms by inhibiting NF-kappaB and proinflammatory cytokines. J Mol Med (Berl). 2016;94:195\u2013206.","journal-title":"J Mol Med (Berl)"},{"key":"1832_CR103","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1089\/ars.2006.8.76","volume":"8","author":"HY Cho","year":"2006","unstructured":"Cho HY, Reddy SP, Kleeberger SR. Nrf2 defends the lung from oxidative stress. Antioxid Redox Signal. 2006;8:76\u201387.","journal-title":"Antioxid Redox Signal"},{"key":"1832_CR104","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.foodchem.2014.11.090","volume":"174","author":"MS Lee","year":"2015","unstructured":"Lee MS, Lee B, Park KE, Utsuki T, Shin T, Oh CW, et al. Dieckol enhances the expression of antioxidant and detoxifying enzymes by the activation of Nrf2-MAPK signalling pathway in HepG2 cells. Food Chem. 2015;174:538\u201346.","journal-title":"Food Chem"},{"key":"1832_CR105","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1042\/BST20150014","volume":"43","author":"JD Wardyn","year":"2015","unstructured":"Wardyn JD, Ponsford AH, Sanderson CM. Dissecting molecular cross-talk between Nrf2 and NF-kappaB response pathways. Biochem Soc Trans. 2015;43:621\u20136.","journal-title":"Biochem Soc Trans"},{"key":"1832_CR106","first-page":"12","volume":"690","author":"J Kim","year":"2010","unstructured":"Kim J, Cha YN, Surh YJ. A protective role of nuclear factor-erythroid 2-related factor-2 (Nrf2) in inflammatory disorders. Mutat Res. 2010;690:12\u201323.","journal-title":"Mutat Res"},{"key":"1832_CR107","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.freeradbiomed.2011.12.016","volume":"52","author":"E Lee","year":"2012","unstructured":"Lee E, Yin Z, Sidoryk-Wegrzynowicz M, Jiang H, Aschner M. 15-Deoxy-Delta12,14-prostaglandin J(2) modulates manganese-induced activation of the NF-kappaB, Nrf2, and PI3K pathways in astrocytes. Free Radic Biol Med. 2012;52:1067\u201374.","journal-title":"Free Radic Biol Med"},{"key":"1832_CR108","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0006-8993(96)01308-X","volume":"752","author":"J Ballabriga","year":"1997","unstructured":"Ballabriga J, Pozas E, Planas AM, Ferrer I. bFGF and FGFR-3 immunoreactivity in the rat brain following systemic kainic acid administration at convulsant doses: localization of bFGF and FGFR-3 in reactive astrocytes, and FGFR-3 in reactive microglia. Brain Res. 1997;752:315\u20138.","journal-title":"Brain Res"},{"key":"1832_CR109","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1046\/j.0021-8782.2001.00002.x","volume":"200","author":"DR Goddard","year":"2002","unstructured":"Goddard DR, Berry M, Kirvell SL, Butt AM. Fibroblast growth factor-2 induces astroglial and microglial reactivity in vivo. J Anat. 2002;200:57\u201367.","journal-title":"J Anat"},{"key":"1832_CR110","doi-asserted-by":"crossref","unstructured":"Wang J, Xing L, Song Y, Yang Y, Zhang Y, Ma H, et al. FGFs\/FGFRs and neuroinflammatory diseases: mechanism, drug therapies and delivery systems. J Adv Res. 2025:78:733\u201356.","DOI":"10.1016\/j.jare.2025.06.024"},{"key":"1832_CR111","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.1097\/00001756-199611040-00081","volume":"7","author":"T Di Pucchio","year":"1996","unstructured":"Di Pucchio T, Ennas MG, Presta M, Lauro GM. Basic fibroblast growth factor modulates in vitro differentiation of human fetal microglia. Neuroreport. 1996;7:2813\u20137.","journal-title":"Neuroreport"},{"key":"1832_CR112","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3389\/fncel.2018.00255","volume":"12","author":"MM Tang","year":"2018","unstructured":"Tang MM, Lin WJ, Pan YQ, Li YC. Fibroblast growth factor 2 modulates hippocampal microglia activation in a neuroinflammation induced model of depression. Front Cell Neurosci. 2018;12:255.","journal-title":"Front Cell Neurosci"},{"key":"1832_CR113","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-11-76","volume":"11","author":"M Noda","year":"2014","unstructured":"Noda M, Takii K, Parajuli B, Kawanokuchi J, Sonobe Y, Takeuchi H, et al. FGF-2 released from degenerating neurons exerts microglial-induced neuroprotection via FGFR3-ERK signaling pathway. J Neuroinflammation. 2014;11:76.","journal-title":"J Neuroinflammation"},{"key":"1832_CR114","doi-asserted-by":"publisher","first-page":"10951","DOI":"10.18632\/aging.103308","volume":"12","author":"S Li","year":"2020","unstructured":"Li S, Lu Y, Ding D, Ma Z, Xing X, Hua X, et al. Fibroblast growth factor 2 contributes to the effect of salidroside on dendritic and synaptic plasticity after cerebral ischemia\/reperfusion injury. Aging (Albany NY). 2020;12:10951\u201368.","journal-title":"Aging (Albany NY)"},{"key":"1832_CR115","doi-asserted-by":"publisher","first-page":"15918","DOI":"10.1074\/jbc.271.27.15918","volume":"271","author":"M Yamasaki","year":"1996","unstructured":"Yamasaki M, Miyake A, Tagashira S, Itoh N. Structure and expression of the rat mRNA encoding a novel member of the fibroblast growth factor family. J Biol Chem. 1996;271:15918\u201321.","journal-title":"J Biol Chem"},{"key":"1832_CR116","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.brainresbull.2018.10.013","volume":"143","author":"H Bai","year":"2018","unstructured":"Bai H, Zhao L, Liu H, Guo H, Guo W, Zheng L, et al. Adiponectin confers neuroprotection against cerebral ischemia-reperfusion injury through activating the cAMP\/PKA-CREB-BDNF signaling. Brain Res Bull. 2018;143:145\u201354.","journal-title":"Brain Res Bull"},{"key":"1832_CR117","doi-asserted-by":"publisher","first-page":"3671","DOI":"10.1523\/JNEUROSCI.3735-16.2017","volume":"37","author":"Q Bu","year":"2017","unstructured":"Bu Q, Wang A, Hamzah H, Waldman A, Jiang K, Dong Q, et al. CREB signaling is involved in Rett syndrome pathogenesis. J Neurosci. 2017;37:3671\u201385.","journal-title":"J Neurosci"},{"key":"1832_CR118","doi-asserted-by":"publisher","first-page":"L550","DOI":"10.1152\/ajplung.00329.2006","volume":"292","author":"JT Benjamin","year":"2007","unstructured":"Benjamin JT, Smith RJ, Halloran BA, Day TJ, Kelly DR, Prince LS. FGF-10 is decreased in bronchopulmonary dysplasia and suppressed by Toll-like receptor activation. Am J Physiol Lung Cell Mol Physiol. 2007;292:L550\u20138.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"1832_CR119","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.cmet.2007.05.003","volume":"5","author":"T Inagaki","year":"2007","unstructured":"Inagaki T, Dutchak P, Zhao G, Ding X, Gautron L, Parameswara V, et al. Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21. Cell Metab. 2007;5:415\u201325.","journal-title":"Cell Metab"},{"key":"1832_CR120","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/cen.12095","volume":"78","author":"YC Woo","year":"2013","unstructured":"Woo YC, Xu A, Wang Y, Lam KS. Fibroblast growth factor 21 as an emerging metabolic regulator: clinical perspectives. Clin Endocrinol (Oxf). 2013;78:489\u201396.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1832_CR121","doi-asserted-by":"publisher","first-page":"12553","DOI":"10.1073\/pnas.1006962107","volume":"107","author":"MD Chau","year":"2010","unstructured":"Chau MD, Gao J, Yang Q, Wu Z, Gromada J. Fibroblast growth factor 21 regulates energy metabolism by activating the AMPK-SIRT1-PGC-1alpha pathway. Proc Natl Acad Sci USA. 2010;107:12553\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1832_CR122","doi-asserted-by":"crossref","unstructured":"Jiang Y, Lin L, Liu N, Wang Q, Yuan J, Li Y, et al. FGF21 protects against aggravated blood-brain barrier disruption after ischemic focal stroke in diabetic db\/db male mice via cerebrovascular PPARgamma activation. Int J Mol Sci. 2020;21:824.","DOI":"10.3390\/ijms21030824"},{"key":"1832_CR123","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1210\/me.2010-0142","volume":"24","author":"K Fon Tacer","year":"2010","unstructured":"Fon Tacer K, Bookout AL, Ding X, Kurosu H, John GB, Wang L, et al. Research resource: Comprehensive expression atlas of the fibroblast growth factor system in adult mouse. Mol Endocrinol. 2010;24:2050\u201364.","journal-title":"Mol Endocrinol"},{"key":"1832_CR124","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1038\/nm.3249","volume":"19","author":"AL Bookout","year":"2013","unstructured":"Bookout AL, de Groot MH, Owen BM, Lee S, Gautron L, Lawrence HL, et al. FGF21 regulates metabolism and circadian behavior by acting on the nervous system. Nat Med. 2013;19:1147\u201352.","journal-title":"Nat Med"},{"key":"1832_CR125","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1007\/s00415-020-09830-3","volume":"267","author":"M Gersel Stokholm","year":"2020","unstructured":"Gersel Stokholm M, Garrido A, Tolosa E, Serradell M, Iranzo A, Ostergaard K, et al. Imaging dopamine function and microglia in asymptomatic LRRK2 mutation carriers. J Neurol. 2020;267:2296\u2013300.","journal-title":"J Neurol"},{"key":"1832_CR126","doi-asserted-by":"publisher","first-page":"4057","DOI":"10.2337\/db14-0595","volume":"63","author":"KR Markan","year":"2014","unstructured":"Markan KR, Naber MC, Ameka MK, Anderegg MD, Mangelsdorf DJ, Kliewer SA, et al. Circulating FGF21 is liver derived and enhances glucose uptake during refeeding and overfeeding. Diabetes. 2014;63:4057\u201363.","journal-title":"Diabetes"},{"key":"1832_CR127","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-015-0270-3","volume":"12","author":"J Pan","year":"2015","unstructured":"Pan J, Jin JL, Ge HM, Yin KL, Chen X, Han LJ, et al. Malibatol A regulates microglia M1\/M2 polarization in experimental stroke in a PPARgamma-dependent manner. J Neuroinflammation. 2015;12:51.","journal-title":"J Neuroinflammation"},{"key":"1832_CR128","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.intimp.2016.05.026","volume":"38","author":"Y Yu","year":"2016","unstructured":"Yu Y, He J, Li S, Song L, Guo X, Yao W, et al. Fibroblast growth factor 21 (FGF21) inhibits macrophage-mediated inflammation by activating Nrf2 and suppressing the NF-kappaB signaling pathway. Int Immunopharmacol. 2016;38:144\u201352.","journal-title":"Int Immunopharmacol"},{"key":"1832_CR129","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-020-01921-2","volume":"17","author":"D Wang","year":"2020","unstructured":"Wang D, Liu F, Zhu L, Lin P, Han F, Wang X, et al. FGF21 alleviates neuroinflammation following ischemic stroke by modulating the temporal and spatial dynamics of microglia\/macrophages. J Neuroinflammation. 2020;17:257.","journal-title":"J Neuroinflammation"},{"key":"1832_CR130","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.744868","volume":"12","author":"Y Liu","year":"2021","unstructured":"Liu Y, Liu Y, Deng J, Li W, Nie X. Fibroblast growth factor in diabetic foot ulcer: progress and therapeutic prospects. Front Endocrinol (Lausanne). 2021;12:744868.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1832_CR131","unstructured":"Dotiwala AK, McCausland C, Samra NS. Anatomy, head and neck: blood brain barrier. In: StatPearls. Treasure Island (FL); 2025."},{"key":"1832_CR132","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.nbd.2012.01.008","volume":"46","author":"B Huang","year":"2012","unstructured":"Huang B, Krafft PR, Ma Q, Rolland WB, Caner B, Lekic T, et al. Fibroblast growth factors preserve blood-brain barrier integrity through RhoA inhibition after intracerebral hemorrhage in mice. Neurobiol Dis. 2012;46:204\u201314.","journal-title":"Neurobiol Dis"},{"key":"1832_CR133","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.cytogfr.2005.01.004","volume":"16","author":"M Presta","year":"2005","unstructured":"Presta M, Dell\u2019Era P, Mitola S, Moroni E, Ronca R, Rusnati M. Fibroblast growth factor\/fibroblast growth factor receptor system in angiogenesis. Cytokine Growth Factor Rev. 2005;16:159\u201378.","journal-title":"Cytokine Growth Factor Rev"},{"key":"1832_CR134","first-page":"910","volume":"9","author":"F Wu","year":"2017","unstructured":"Wu F, Chen Z, Tang C, Zhang J, Cheng L, Zuo H, et al. Acid fibroblast growth factor preserves blood-brain barrier integrity by activating the PI3K-Akt-Rac1 pathway and inhibiting RhoA following traumatic brain injury. Am J Transl Res. 2017;9:910\u201325.","journal-title":"Am J Transl Res"},{"key":"1832_CR135","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3389\/fphar.2020.00059","volume":"11","author":"Y Zou","year":"2020","unstructured":"Zou Y, Hu J, Huang W, Ye S, Han F, Du J, et al. Non-mitogenic fibroblast growth factor 1 enhanced angiogenesis following ischemic stroke by regulating the sphingosine-1-phosphate 1 pathway. Front Pharmacol. 2020;11:59.","journal-title":"Front Pharmacol"},{"key":"1832_CR136","doi-asserted-by":"publisher","first-page":"3371","DOI":"10.1091\/mbc.e17-03-0136","volume":"28","author":"NR Reinhard","year":"2017","unstructured":"Reinhard NR, Mastop M, Yin T, Wu Y, Bosma EK, Gadella TWJ Jr, et al. The balance between Galphai-Cdc42\/Rac and Galpha12\/13-RhoA pathways determines endothelial barrier regulation by sphingosine-1-phosphate. Mol Biol Cell. 2017;28:3371\u201382.","journal-title":"Mol Biol Cell"},{"key":"1832_CR137","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.4155\/fmc-2018-0103","volume":"10","author":"WJ Xue","year":"2018","unstructured":"Xue WJ, Li MT, Chen L, Sun LP, Li YY. Recent developments and advances of FGFR as a potential target in cancer. Future Med Chem. 2018;10:2109\u201326.","journal-title":"Future Med Chem"},{"key":"1832_CR138","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.biopha.2017.08.059","volume":"95","author":"HJ Sun","year":"2017","unstructured":"Sun HJ, Cai WW, Gong LL, Wang X, Zhu XX, Wan MY, et al. FGF-2-mediated FGFR1 signaling in human microvascular endothelial cells is activated by vaccarin to promote angiogenesis. Biomed Pharmacother. 2017;95:144\u201352.","journal-title":"Biomed Pharmacother"},{"key":"1832_CR139","doi-asserted-by":"publisher","first-page":"10935","DOI":"10.1096\/fj.201900282R","volume":"33","author":"H Li","year":"2019","unstructured":"Li H, Zhou X, Li Y, Ma X, Gonzales RJ, Qiu S, et al. The selective sphingosine 1-phosphate receptor 1 modulator RP101075 improves microvascular circulation after cerebrovascular thrombosis. FASEB J. 2019;33:10935\u201341.","journal-title":"FASEB J"},{"key":"1832_CR140","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.1007\/s12035-017-0544-0","volume":"55","author":"L Lin","year":"2018","unstructured":"Lin L, Wang Q, Qian K, Cao Z, Xiao J, Wang X, et al. bFGF protects against oxygen glucose deprivation\/reoxygenation-induced endothelial monolayer permeability via S1PR1-dependent mechanisms. Mol Neurobiol. 2018;55:3131\u201342.","journal-title":"Mol Neurobiol"},{"key":"1832_CR141","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1091\/mbc.4.10.973","volume":"4","author":"S Klein","year":"1993","unstructured":"Klein S, Giancotti FG, Presta M, Albelda SM, Buck CA, Rifkin DB. Basic fibroblast growth factor modulates integrin expression in microvascular endothelial cells. Mol Biol Cell. 1993;4:973\u201382.","journal-title":"Mol Biol Cell"},{"key":"1832_CR142","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1083\/jcb.141.7.1659","volume":"141","author":"G Seghezzi","year":"1998","unstructured":"Seghezzi G, Patel S, Ren CJ, Gualandris A, Pintucci G, Robbins ES, et al. Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: an autocrine mechanism contributing to angiogenesis. J Cell Biol. 1998;141:1659\u201373.","journal-title":"J Cell Biol"},{"key":"1832_CR143","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1080\/01616412.1995.11740300","volume":"17","author":"E Frank","year":"1995","unstructured":"Frank E, Ragel B. Cortical basic fibroblast factor expression after head injury: preliminary results. Neurol Res. 1995;17:129\u201331.","journal-title":"Neurol Res"},{"key":"1832_CR144","doi-asserted-by":"publisher","first-page":"3828","DOI":"10.1523\/JNEUROSCI.12-10-03828.1992","volume":"12","author":"A Logan","year":"1992","unstructured":"Logan A, Frautschy SA, Gonzalez AM, Baird A. A time course for the focal elevation of synthesis of basic fibroblast growth factor and one of its high-affinity receptors (flg) following a localized cortical brain injury. J Neurosci. 1992;12:3828\u201337.","journal-title":"J Neurosci"},{"key":"1832_CR145","doi-asserted-by":"publisher","first-page":"15292","DOI":"10.1074\/jbc.271.25.15292","volume":"271","author":"DM Ornitz","year":"1996","unstructured":"Ornitz DM, Xu J, Colvin JS, McEwen DG, MacArthur CA, Coulier F, et al. Receptor specificity of the fibroblast growth factor family. J Biol Chem. 1996;271:15292\u20137.","journal-title":"J Biol Chem"},{"key":"1832_CR146","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1111\/j.1601-183X.2007.00357.x","volume":"7","author":"K Scearce-Levie","year":"2008","unstructured":"Scearce-Levie K, Roberson ED, Gerstein H, Cholfin JA, Mandiyan VS, Shah NM, et al. Abnormal social behaviors in mice lacking Fgf17. Genes Brain Behav. 2008;7:344\u201354.","journal-title":"Genes Brain Behav"},{"key":"1832_CR147","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2024.176521","volume":"971","author":"WT Huang","year":"2024","unstructured":"Huang WT, Chen XJ, Lin YK, Shi JF, Li H, Wu HD, et al. FGF17 protects cerebral ischemia reperfusion-induced blood-brain barrier disruption via FGF receptor 3-mediated PI3K\/AKT signaling pathway. Eur J Pharmacol. 2024;971:176521.","journal-title":"Eur J Pharmacol"},{"key":"1832_CR148","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1007\/s12975-023-01196-8","volume":"15","author":"PT Do","year":"2024","unstructured":"Do PT, Chuang DM, Wu CC, Huang CZ, Chen YH, Kang SJ, et al. Mesenchymal stem cells overexpressing FGF21 preserve blood-brain barrier integrity in experimental ischemic stroke. Transl Stroke Res. 2024;15:1165\u201375.","journal-title":"Transl Stroke Res"},{"key":"1832_CR149","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jphs.2019.03.010","volume":"140","author":"W Huang","year":"2019","unstructured":"Huang W, Shao M, Liu H, Chen J, Hu J, Zhu L, et al. Fibroblast growth factor 21 enhances angiogenesis and wound healing of human brain microvascular endothelial cells by activating PPARgamma. J Pharmacol Sci. 2019;140:120\u20137.","journal-title":"J Pharmacol Sci"},{"key":"1832_CR150","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1136\/jnnp.67.4.420","volume":"67","author":"G Devuyst","year":"1999","unstructured":"Devuyst G, Bogousslavsky J. Recent progress in drug treatment for acute stroke. J Neurol Neurosurg Psychiatry. 1999;67:420\u20135.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1832_CR151","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1159\/000049128","volume":"11","author":"G Devuyst","year":"2001","unstructured":"Devuyst G, Bogousslavsky J. Recent progress in drug treatment for acute ischemic stroke. Cerebrovasc Dis. 2001;11:71\u20139.","journal-title":"Cerebrovasc Dis"},{"key":"1832_CR152","doi-asserted-by":"publisher","first-page":"S66","DOI":"10.1212\/WNL.49.5_Suppl_4.S66","volume":"49","author":"KR Lees","year":"1997","unstructured":"Lees KR. Cerestat and other NMDA antagonists in ischemic stroke. Neurology. 1997;49:S66\u20139.","journal-title":"Neurology"},{"key":"1832_CR153","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1016\/S0140-6736(00)02326-6","volume":"355","author":"KR Lees","year":"2000","unstructured":"Lees KR, Asplund K, Carolei A, Davis SM, Diener HC, Kaste M, et al. Glycine antagonist (gavestinel) in neuroprotection (GAIN International) in patients with acute stroke: a randomised controlled trial. GAIN International Investigators. Lancet. 2000;355:1949\u201354.","journal-title":"GAIN International Investigators. Lancet"},{"key":"1832_CR154","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1161\/01.STR.31.11.2543","volume":"31","author":"HC Diener","year":"2000","unstructured":"Diener HC, Cortens M, Ford G, Grotta J, Hacke W, Kaste M, et al. Lubeluzole in acute ischemic stroke treatment: a double-blind study with an 8-hour inclusion window comparing a 10-mg daily dose of lubeluzole with placebo. Stroke. 2000;31:2543\u201351.","journal-title":"Stroke"},{"key":"1832_CR155","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.1161\/01.STR.30.12.2592","volume":"30","author":"WM Clark","year":"1999","unstructured":"Clark WM, Williams BJ, Selzer KA, Zweifler RM, Sabounjian LA, Gammans RE. A randomized efficacy trial of citicoline in patients with acute ischemic stroke. Stroke. 1999;30:2592\u20137.","journal-title":"Stroke"},{"key":"1832_CR156","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1161\/01.STR.31.9.2257","volume":"31","author":"Tirilazad mesylate in acute ischemic stroke: a systematic review","year":"2000","unstructured":"Tirilazad mesylate in acute ischemic stroke: a systematic review. Tirilazad International Steering Committee. Stroke. 2000;31:2257\u201365.","journal-title":"Stroke"},{"key":"1832_CR157","doi-asserted-by":"publisher","first-page":"S62","DOI":"10.1212\/WNL.51.3_Suppl_3.S62","volume":"51","author":"TJ DeGraba","year":"1998","unstructured":"DeGraba TJ. The role of inflammation after acute stroke: utility of pursuing anti-adhesion molecule therapy. Neurology. 1998;51:S62\u20138.","journal-title":"Neurology"},{"key":"1832_CR158","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1161\/01.STR.30.1.21","volume":"30","author":"NG Wahlgren","year":"1999","unstructured":"Wahlgren NG, Ranasinha KW, Rosolacci T, Franke CL, van Erven PM, Ashwood T, et al. Clomethiazole acute stroke study (CLASS): results of a randomized, controlled trial of clomethiazole versus placebo in 1360 acute stroke patients. Stroke. 1999;30:21\u20138.","journal-title":"Stroke"},{"key":"1832_CR159","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1159\/000065683","volume":"14","author":"J Bogousslavsky","year":"2002","unstructured":"Bogousslavsky J, Victor SJ, Salinas EO, Pallay A, Donnan GA, Fieschi C, et al. Fiblast (trafermin) in acute stroke: results of the European-Australian phase II\/III safety and efficacy trial. Cerebrovasc Dis. 2002;14:239\u201351.","journal-title":"Cerebrovasc Dis"},{"key":"1832_CR160","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1038\/jcbfm.1995.121","volume":"15","author":"M Fisher","year":"1995","unstructured":"Fisher M, Meadows ME, Do T, Weise J, Trubetskoy V, Charette M, et al. Delayed treatment with intravenous basic fibroblast growth factor reduces infarct size following permanent focal cerebral ischemia in rats. J Cereb Blood Flow Metab. 1995;15:953\u20139.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1832_CR161","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0014-2999(97)89672-0","volume":"327","author":"JM Ren","year":"1997","unstructured":"Ren JM, Finklestein SP. Time window of infarct reduction by intravenous basic fibroblast growth factor in focal cerebral ischemia. Eur J Pharmacol. 1997;327:11\u20136.","journal-title":"Eur J Pharmacol"},{"key":"1832_CR162","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/0022-510X(96)00052-4","volume":"139","author":"N Jiang","year":"1996","unstructured":"Jiang N, Finklestein SP, Do T, Caday CG, Charette M, Chopp M. Delayed intravenous administration of basic fibroblast growth factor (bFGF) reduces infarct volume in a model of focal cerebral ischemia\/reperfusion in the rat. J Neurol Sci. 1996;139:173\u20139.","journal-title":"J Neurol Sci"},{"key":"1832_CR163","doi-asserted-by":"publisher","first-page":"8179","DOI":"10.1073\/pnas.94.15.8179","volume":"94","author":"T Kawamata","year":"1997","unstructured":"Kawamata T, Dietrich WD, Schallert T, Gotts JE, Cocke RR, Benowitz LI, et al. Intracisternal basic fibroblast growth factor enhances functional recovery and up-regulates the expression of a molecular marker of neuronal sprouting following focal cerebral infarction. Proc Natl Acad Sci USA. 1997;94:8179\u201384.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1832_CR164","doi-asserted-by":"crossref","unstructured":"Benington L, Rajan G, Locher C, Lim LY. Fibroblast growth factor 2-a review of stabilisation approaches for clinical applications. Pharmaceutics. 2020;12:508.","DOI":"10.3390\/pharmaceutics12060508"},{"key":"1832_CR165","doi-asserted-by":"crossref","unstructured":"Hui Q, Jin Z, Li X, Liu C, Wang X. FGF family: from drug development to clinical application. Int J Mol Sci. 2018;19:1875.","DOI":"10.3390\/ijms19071875"},{"key":"1832_CR166","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2202-9-S3-S5","volume":"9","author":"LR Hanson","year":"2008","unstructured":"Hanson LR, Frey WH 2nd. Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease. BMC Neurosci. 2008;9:S5.","journal-title":"BMC Neurosci"},{"key":"1832_CR167","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.neuropharm.2018.04.017","volume":"137","author":"EL Boshoff","year":"2018","unstructured":"Boshoff EL, Fletcher EJR, Duty S. Fibroblast growth factor 20 is protective towards dopaminergic neurons in vivo in a paracrine manner. Neuropharmacology. 2018;137:156\u201363.","journal-title":"Neuropharmacology"},{"key":"1832_CR168","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.jbiosc.2008.12.013","volume":"107","author":"H Shimada","year":"2009","unstructured":"Shimada H, Yoshimura N, Tsuji A, Kunisada T. Differentiation of dopaminergic neurons from human embryonic stem cells: modulation of differentiation by FGF-20. J Biosci Bioeng. 2009;107:447\u201354.","journal-title":"J Biosci Bioeng"},{"key":"1832_CR169","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2023.1117057","volume":"17","author":"K Chen","year":"2023","unstructured":"Chen K, Huang W, Wang J, Xu H, Ruan L, Li Y, et al. Increased serum fibroblast growth factor 21 levels are associated with adverse clinical outcomes after intracerebral hemorrhage. Front Neurosci. 2023;17:1117057.","journal-title":"Front Neurosci"},{"key":"1832_CR170","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/s41574-020-0386-0","volume":"16","author":"L Geng","year":"2020","unstructured":"Geng L, Lam KSL, Xu A. The therapeutic potential of FGF21 in metabolic diseases: from bench to clinic. Nat Rev Endocrinol. 2020;16:654\u201367.","journal-title":"Nat Rev Endocrinol"},{"key":"1832_CR171","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.neulet.2005.09.043","volume":"393","author":"H Guo","year":"2006","unstructured":"Guo H, Huang L, Cheng M, Jin X, Zhao Y, Yi M. Serial measurement of serum basic fibroblast growth factor in patients with acute cerebral infarction. Neurosci Lett. 2006;393:56\u20139.","journal-title":"Neurosci Lett"},{"key":"1832_CR172","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/ene.14683","volume":"28","author":"X Zheng","year":"2021","unstructured":"Zheng X, Zhu Z, Guo D, Zhong C, Xu T, Peng Y, et al. Prognostic value of plasma fibroblast growth factor 21 among patients with acute ischemic stroke. Eur J Neurol. 2021;28:844\u201351.","journal-title":"Eur J Neurol"},{"key":"1832_CR173","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.metabol.2018.11.006","volume":"93","author":"KL Ong","year":"2019","unstructured":"Ong KL, Hui N, Januszewski AS, Kaakoush NO, Xu A, Fayyad R, et al. High plasma FGF21 levels predicts major cardiovascular events in patients treated with atorvastatin (from the Treating to New Targets [TNT] Study). Metabolism. 2019;93:93\u20139.","journal-title":"Metabolism"},{"key":"1832_CR174","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.834967","volume":"9","author":"G Wu","year":"2022","unstructured":"Wu G, Wu S, Yan J, Gao S, Zhu J, Yue M, et al. Fibroblast growth factor 21 predicts short-term prognosis in patients with acute heart failure: a prospective cohort study. Front Cardiovasc Med. 2022;9:834967.","journal-title":"Front Cardiovasc Med"},{"key":"1832_CR175","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1136\/neurintsurg-2020-016118","volume":"13","author":"B Maglinger","year":"2021","unstructured":"Maglinger B, Frank JA, McLouth CJ, Trout AL, Roberts JM, Grupke S, et al. Proteomic changes in intracranial blood during human ischemic stroke. J Neurointerv Surg. 2021;13:395\u20139.","journal-title":"J Neurointerv Surg"},{"key":"1832_CR176","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1161\/STROKEAHA.110.604249","volume":"42","author":"Y Wang","year":"2011","unstructured":"Wang Y, Liao X, Zhao X, Wang DZ, Wang C, Nguyen-Huynh MN, et al. Using recombinant tissue plasminogen activator to treat acute ischemic stroke in China: analysis of the results from the Chinese National Stroke Registry (CNSR). Stroke. 2011;42:1658\u201364.","journal-title":"Stroke"},{"key":"1832_CR177","doi-asserted-by":"publisher","first-page":"3076","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.06.040","volume":"27","author":"XY Yao","year":"2018","unstructured":"Yao XY, Li S, Zhang LG, Liu ZH, Bao JN, Wu ZY. Higher serum fibroblast growth factor-23 levels and the risk of stroke and its subtypes: evidence from a meta-analysis of prospective studies. J Stroke Cerebrovasc Dis. 2018;27:3076\u201383.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"1832_CR178","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1111\/j.1476-5381.2010.00750.x","volume":"160","author":"TK Ma","year":"2010","unstructured":"Ma TK, Kam KK, Yan BP, Lam YY. Renin-angiotensin-aldosterone system blockade for cardiovascular diseases: current status. Br J Pharmacol. 2010;160:1273\u201392.","journal-title":"Br J Pharmacol"},{"key":"1832_CR179","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.atherosclerosis.2009.05.013","volume":"207","author":"MA Mirza","year":"2009","unstructured":"Mirza MA, Larsson A, Melhus H, Lind L, Larsson TE. Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population. Atherosclerosis. 2009;207:546\u201351.","journal-title":"Atherosclerosis"},{"key":"1832_CR180","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2020.608517","volume":"11","author":"K Zheng","year":"2020","unstructured":"Zheng K, Lin L, Cui P, Liu T, Chen L, Yang C, et al. Association of fibroblast growth factor 23 with ischemic stroke and its subtypes: a Mendelian randomization study. Front Genet. 2020;11:608517.","journal-title":"Front Genet"},{"key":"1832_CR181","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1212\/WNL.0000000000000410","volume":"82","author":"CB Wright","year":"2014","unstructured":"Wright CB, Dong C, Stark M, Silverberg S, Rundek T, Elkind MS, et al. Plasma FGF23 and the risk of stroke: the Northern Manhattan Study (NOMAS). Neurology. 2014;82:1700\u20136.","journal-title":"Neurology"},{"key":"1832_CR182","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1161\/STROKEAHA.114.007489","volume":"46","author":"B Panwar","year":"2015","unstructured":"Panwar B, Jenny NS, Howard VJ, Wadley VG, Muntner P, Kissela BM, et al. Fibroblast growth factor 23 and risk of incident stroke in community-living adults. Stroke. 2015;46:322\u20138.","journal-title":"Stroke"},{"key":"1832_CR183","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1681\/ASN.2010121224","volume":"22","author":"J Kendrick","year":"2011","unstructured":"Kendrick J, Cheung AK, Kaufman JS, Greene T, Roberts WL, Smits G, et al. FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis. J Am Soc Nephrol. 2011;22:1913\u201322.","journal-title":"J Am Soc Nephrol"},{"key":"1832_CR184","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1159\/000074808","volume":"17","author":"NG Wahlgren","year":"2004","unstructured":"Wahlgren NG, Ahmed N. Neuroprotection in cerebral ischaemia: facts and fancies-the need for new approaches. Cerebrovasc Dis. 2004;17:153\u201366.","journal-title":"Cerebrovasc Dis"},{"key":"1832_CR185","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S1474-4422(21)00252-0","volume":"20","author":"GBDS Collaborators","year":"2021","unstructured":"Collaborators GBDS. Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 2021;20:795\u2013820.","journal-title":"Lancet Neurol"},{"key":"1832_CR186","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.2174\/1570159X18666200720173316","volume":"18","author":"Y Yang","year":"2020","unstructured":"Yang Y, Torbey MT. Angiogenesis and blood-brain barrier permeability in vascular remodeling after stroke. Curr Neuropharmacol. 2020;18:1250\u201365.","journal-title":"Curr Neuropharmacol"},{"key":"1832_CR187","doi-asserted-by":"publisher","DOI":"10.1016\/j.vph.2025.107466","volume":"158","author":"JS Kim","year":"2025","unstructured":"Kim JS, Park M, Park YA, Lee DH, Choi SA, Jang EJ, et al. Effects of FGF-related gene polymorphisms on cerebral infarction in patients treated with direct oral anticoagulants. Vascul Pharmacol. 2025;158:107466.","journal-title":"Vascul Pharmacol"},{"key":"1832_CR188","doi-asserted-by":"publisher","first-page":"781","DOI":"10.2174\/1389450121666200107100747","volume":"21","author":"S Asgharzade","year":"2020","unstructured":"Asgharzade S, Talaei A, Farkhondeh T, Forouzanfar F. Combining growth factor and stem cell therapy for stroke rehabilitation, a review. Curr Drug Targets. 2020;21:781\u201391.","journal-title":"Curr Drug Targets"},{"key":"1832_CR189","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioadv.2023.213396","volume":"149","author":"M Han","year":"2023","unstructured":"Han M, Zhang Z, Liu Z, Liu Y, Zhao H, Wang B, et al. Three-dimensional-cultured MSC-derived exosome with hydrogel for cerebral ischemia repair. Biomater Adv. 2023;149:213396.","journal-title":"Biomater Adv"},{"key":"1832_CR190","doi-asserted-by":"crossref","unstructured":"Zhao L, Zhou Y, Zhang J, Liang H, Chen X, Tan H. Natural polymer-based hydrogels: from polymer to biomedical applications. Pharmaceutics. 2023;15:2514.","DOI":"10.3390\/pharmaceutics15102514"},{"key":"1832_CR191","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41401-025-01640-5","volume":"47","author":"H Guo","year":"2026","unstructured":"Guo H, Liu WC, Sun YY, Jin XC, Geng PP. Neuroglia and immune cells play different roles in neuroinflammation and neuroimmune response in post-stroke neural injury and repair. Acta Pharmacol Sin. 2026;47:273\u201389.","journal-title":"Acta Pharmacol Sin"},{"key":"1832_CR192","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2022.121904","volume":"291","author":"X Li","year":"2022","unstructured":"Li X, Han Z, Wang T, Ma C, Li H, Lei H, et al. Cerium oxide nanoparticles with antioxidative neurorestoration for ischemic stroke. Biomaterials. 2022;291:121904.","journal-title":"Biomaterials"},{"key":"1832_CR193","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2020.119942","volume":"243","author":"HY Kim","year":"2020","unstructured":"Kim HY, Kim TJ, Kang L, Kim YJ, Kang MK, Kim J, et al. Mesenchymal stem cell-derived magnetic extracellular nanovesicles for targeting and treatment of ischemic stroke. Biomaterials. 2020;243:119942.","journal-title":"Biomaterials"},{"key":"1832_CR194","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.jconrel.2016.01.017","volume":"224","author":"YZ Zhao","year":"2016","unstructured":"Zhao YZ, Lin M, Lin Q, Yang W, Yu XC, Tian FR, et al. Intranasal delivery of bFGF with nanoliposomes enhances in vivo neuroprotection and neural injury recovery in a rodent stroke model. J Control Release. 2016;224:165\u201375.","journal-title":"J Control Release"},{"key":"1832_CR195","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1111\/j.1471-4159.2007.05070.x","volume":"104","author":"S Li","year":"2008","unstructured":"Li S, Christensen C, Kiselyov VV, Kohler LB, Bock E, Berezin V. Fibroblast growth factor-derived peptides: functional agonists of the fibroblast growth factor receptor. J Neurochem. 2008;104:667\u201382.","journal-title":"J Neurochem"},{"key":"1832_CR196","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1101\/gad.1365406","volume":"20","author":"SK Olsen","year":"2006","unstructured":"Olsen SK, Li JY, Bromleigh C, Eliseenkova AV, Ibrahimi OA, Lao Z, et al. Structural basis by which alternative splicing modulates the organizer activity of FGF8 in the brain. Genes Dev. 2006;20:185\u201398.","journal-title":"Genes Dev"},{"key":"1832_CR197","first-page":"1311","volume":"8","author":"DA Clements","year":"1993","unstructured":"Clements DA, Wang JK, Dionne CA, Goldfarb M. Activation of fibroblast growth factor (FGF) receptors by recombinant human FGF-5. Oncogene. 1993;8:1311\u20136.","journal-title":"Oncogene"},{"key":"1832_CR198","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3389\/fgene.2019.00102","volume":"10","author":"A Zinkle","year":"2019","unstructured":"Zinkle A, Mohammadi M. Structural biology of the FGF7 subfamily. Front Genet. 2019;10:102.","journal-title":"Front Genet"},{"key":"1832_CR199","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.cmet.2012.11.001","volume":"16","author":"B Angelin","year":"2012","unstructured":"Angelin B, Larsson TE, Rudling M. Circulating fibroblast growth factors as metabolic regulators-a critical appraisal. Cell Metab. 2012;16:693\u2013705.","journal-title":"Cell Metab"},{"key":"1832_CR200","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1101\/gad.184788.111","volume":"26","author":"MJ Potthoff","year":"2012","unstructured":"Potthoff MJ, Kliewer SA, Mangelsdorf DJ. Endocrine fibroblast growth factors 15\/19 and 21: from feast to famine. Genes Dev. 2012;26:312\u201324.","journal-title":"Genes Dev"},{"key":"1832_CR201","doi-asserted-by":"publisher","first-page":"5165","DOI":"10.1074\/jbc.M109.068783","volume":"285","author":"X Wu","year":"2010","unstructured":"Wu X, Ge H, Lemon B, Vonderfecht S, Weiszmann J, Hecht R, et al. FGF19-induced hepatocyte proliferation is mediated through FGFR4 activation. J Biol Chem. 2010;285:5165\u201370.","journal-title":"J Biol Chem"},{"key":"1832_CR202","doi-asserted-by":"publisher","first-page":"F351","DOI":"10.1152\/ajprenal.00232.2013","volume":"306","author":"J Gattineni","year":"2014","unstructured":"Gattineni J, Alphonse P, Zhang Q, Mathews N, Bates CM, Baum M. Regulation of renal phosphate transport by FGF23 is mediated by FGFR1 and FGFR4. Am J Physiol Renal Physiol. 2014;306:F351\u20138.","journal-title":"Am J Physiol Renal Physiol"},{"key":"1832_CR203","doi-asserted-by":"publisher","first-page":"F371","DOI":"10.1152\/ajprenal.00740.2010","volume":"301","author":"J Gattineni","year":"2011","unstructured":"Gattineni J, Twombley K, Goetz R, Mohammadi M, Baum M. Regulation of serum 1,25(OH)2 vitamin D3 levels by fibroblast growth factor 23 is mediated by FGF receptors 3 and 4. Am J Physiol Renal Physiol. 2011;301:F371\u20137.","journal-title":"Am J Physiol Renal Physiol"},{"key":"1832_CR204","doi-asserted-by":"publisher","first-page":"6120","DOI":"10.1074\/jbc.C500457200","volume":"281","author":"H Kurosu","year":"2006","unstructured":"Kurosu H, Ogawa Y, Miyoshi M, Yamamoto M, Nandi A, Rosenblatt KP, et al. Regulation of fibroblast growth factor-23 signaling by klotho. J Biol Chem. 2006;281:6120\u20133.","journal-title":"J Biol Chem"},{"key":"1832_CR205","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/nature05315","volume":"444","author":"I Urakawa","year":"2006","unstructured":"Urakawa I, Yamazaki Y, Shimada T, Iijima K, Hasegawa H, Okawa K, et al. Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature. 2006;444:770\u20134.","journal-title":"Nature"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01832-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01832-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01832-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T20:02:01Z","timestamp":1789675321000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01832-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,19]]},"references-count":205,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["1832"],"URL":"https:\/\/doi.org\/10.1038\/s41401-026-01832-7","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,19]]},"assertion":[{"value":"6 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}